Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
מצבים רפואיים
HPV-Associated Oropharyngeal Squamous Cell Carcinoma · HPV Positive Oropharyngeal Squamous Cell Carcinoma · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage · HPV-Related Squamous Cell Carcinoma · Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Clinical Stage · HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Pathologic Stage
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Jonathan Schoenfeld, MD, MPH) · jonathan_schoenfeld@dfci.harvard.edu · 617.632.5296Contact: Principal Investigator (Jonathan Schoenfeld, MD, MPH)Dana Farber Cancer Institute, Boston, Massachusetts, United States
Contact: Study coordinator (Jonathan D. Schoenfeld, MD, MPH) · jonathan_schoenfeld@dfci.harvard.edu · 617.632.5296Contact: Principal Investigator (Jonathan D. schoenfeld, MD)
מובילי המחקר
Jonathan D Schoenfeld, MD, MPH
Principal Investigator
Dana-Farber Cancer Institute